Target intelligence / Profile preview

Herpesvirus envelope glycoprotein-heparan sulfate proteoglycan interface (HSV gB/gC-HSPG interface)

Target
HSV gB/gC-HSPG interface
Molecular classification
Viral envelope protein, Glycoprotein, Proteoglycan, Protein-carbohydrate complex
01

Overview

The herpesvirus envelope glycoprotein-heparan sulfate proteoglycan interface is the primary site for the initial attachment of herpesviruses, such as Herpes Simplex Virus (HSV), to host cells. This interaction typically involves viral glycoproteins gC and gB binding to the glycosaminoglycan chains of host cell surface heparan sulfate proteoglycans (HSPGs) [1][2]. This tethering step is crucial for concentrating the virus on the cell surface and facilitating subsequent interactions with entry receptors like nectin-1 or HVEM, leading to membrane fusion [3]. Because this interface is essential for the initiation of infection, it serves as a significant therapeutic target for entry inhibitors [4]. Drugs targeting this interface, such as heparin mimetics or polyanionic compounds, work by competitively binding to the viral glycoproteins, thereby preventing the virus from docking onto the host cell [5].

Other names
Herpesvirus attachment complexgC-HSPG interactiongB-HSPG interactionViral glycoprotein-proteoglycan interfaceHerpesvirus envelope glycoproteins at the host proteoglycan attachment interface
02

Mechanism of action

Competitive inhibition of viral attachment to host cell surface heparan sulfate proteoglycans.

03

Biological functions

Viral attachmentViral entryCell surface tetheringHost-pathogen interaction
04

Disease associations

Herpes simplex virus infectionCytomegalovirus infectionVaricella-zoster virus infectionInfection
05

Safety considerations

Anticoagulant effectsInterference with host growth factor signalingPoor oral bioavailabilityPotential for mucosal irritation
06

Interacting drugs

Muparfostat

5 more in the full profile.

07

Biomarkers

Viral DNA loadViral titerAnti-HSV antibodies

Beyond the preview

Go deeper on Herpesvirus envelope glycoprotein-heparan sulfate proteoglycan interface (HSV gB/gC-HSPG interface).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Herpesvirus envelope glycoprotein-heparan sulfate proteoglycan interface (HSV gB/gC-HSPG interface).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call